S&P 500   3,465.39 (+0.34%)
DOW   28,335.57 (-0.10%)
QQQ   284.74 (+0.20%)
AAPL   115.04 (-0.61%)
MSFT   216.23 (+0.62%)
FB   284.79 (+2.40%)
GOOGL   1,632.98 (+1.64%)
AMZN   3,204.40 (+0.88%)
TSLA   420.63 (-1.21%)
NVDA   543.61 (+1.72%)
BABA   309.92 (+1.19%)
CGC   19.73 (-2.81%)
GE   7.63 (-1.17%)
MU   52.85 (-2.81%)
AMD   81.96 (+3.20%)
T   27.82 (-1.63%)
F   8.16 (-0.61%)
ACB   4.68 (-3.51%)
GILD   60.79 (+0.20%)
NFLX   488.28 (+0.63%)
BA   167.36 (-1.01%)
NIO   27.16 (-0.80%)
DIS   128.35 (+0.62%)
S&P 500   3,465.39 (+0.34%)
DOW   28,335.57 (-0.10%)
QQQ   284.74 (+0.20%)
AAPL   115.04 (-0.61%)
MSFT   216.23 (+0.62%)
FB   284.79 (+2.40%)
GOOGL   1,632.98 (+1.64%)
AMZN   3,204.40 (+0.88%)
TSLA   420.63 (-1.21%)
NVDA   543.61 (+1.72%)
BABA   309.92 (+1.19%)
CGC   19.73 (-2.81%)
GE   7.63 (-1.17%)
MU   52.85 (-2.81%)
AMD   81.96 (+3.20%)
T   27.82 (-1.63%)
F   8.16 (-0.61%)
ACB   4.68 (-3.51%)
GILD   60.79 (+0.20%)
NFLX   488.28 (+0.63%)
BA   167.36 (-1.01%)
NIO   27.16 (-0.80%)
DIS   128.35 (+0.62%)
S&P 500   3,465.39 (+0.34%)
DOW   28,335.57 (-0.10%)
QQQ   284.74 (+0.20%)
AAPL   115.04 (-0.61%)
MSFT   216.23 (+0.62%)
FB   284.79 (+2.40%)
GOOGL   1,632.98 (+1.64%)
AMZN   3,204.40 (+0.88%)
TSLA   420.63 (-1.21%)
NVDA   543.61 (+1.72%)
BABA   309.92 (+1.19%)
CGC   19.73 (-2.81%)
GE   7.63 (-1.17%)
MU   52.85 (-2.81%)
AMD   81.96 (+3.20%)
T   27.82 (-1.63%)
F   8.16 (-0.61%)
ACB   4.68 (-3.51%)
GILD   60.79 (+0.20%)
NFLX   488.28 (+0.63%)
BA   167.36 (-1.01%)
NIO   27.16 (-0.80%)
DIS   128.35 (+0.62%)
S&P 500   3,465.39 (+0.34%)
DOW   28,335.57 (-0.10%)
QQQ   284.74 (+0.20%)
AAPL   115.04 (-0.61%)
MSFT   216.23 (+0.62%)
FB   284.79 (+2.40%)
GOOGL   1,632.98 (+1.64%)
AMZN   3,204.40 (+0.88%)
TSLA   420.63 (-1.21%)
NVDA   543.61 (+1.72%)
BABA   309.92 (+1.19%)
CGC   19.73 (-2.81%)
GE   7.63 (-1.17%)
MU   52.85 (-2.81%)
AMD   81.96 (+3.20%)
T   27.82 (-1.63%)
F   8.16 (-0.61%)
ACB   4.68 (-3.51%)
GILD   60.79 (+0.20%)
NFLX   488.28 (+0.63%)
BA   167.36 (-1.01%)
NIO   27.16 (-0.80%)
DIS   128.35 (+0.62%)
Log in
CVE:NDVA

Indiva Limited (NDVA.V) Stock Forecast, Price & News

C$0.26
+0.01 (+4.08 %)
(As of 10/23/2020 02:09 PM ET)
Add
Compare
Today's Range
C$0.25
Now: C$0.26
C$0.26
50-Day Range
C$0.24
MA: C$0.26
C$0.30
52-Week Range
C$0.16
Now: C$0.26
C$0.48
Volume16,501 shs
Average Volume155,092 shs
Market CapitalizationC$27.62 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Indiva Limited produces and sells medical and recreational cannabis products in Canada. It provides cannabis pre-rolls, flowers, capsules, oils, and edible products; concentrates, extracts, and topicals; and cannabis sugar, salt, and chocolates, as well as accessories. The company offers its products under the INDIVA, Bhang, Wana, Ruby, Sapphire, and Gems brands. Indiva Limited is headquartered in Ottawa, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.32 out of 5 stars

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone888-649-6686
Employees95

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$5.08 million
Cash FlowC$0.00 per share
Book ValueC$0.18 per share

Profitability

Miscellaneous

Market CapC$27.62 million
Next Earnings DateN/A
OptionableNot Optionable
C$0.26
+0.01 (+4.08 %)
(As of 10/23/2020 02:09 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NDVA News and Ratings via Email

Sign-up to receive the latest news and ratings for NDVA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Indiva Limited (NDVA.V) (CVE:NDVA) Frequently Asked Questions

How has Indiva Limited (NDVA.V)'s stock been impacted by COVID-19 (Coronavirus)?

Indiva Limited (NDVA.V)'s stock was trading at C$0.26 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, NDVA shares have decreased by 1.9% and is now trading at C$0.26.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Indiva Limited (NDVA.V)?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Indiva Limited (NDVA.V) in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Indiva Limited (NDVA.V)
.

What price target have analysts set for NDVA?

1 brokers have issued 1-year target prices for Indiva Limited (NDVA.V)'s stock. Their forecasts range from C$0.55 to C$0.55. On average, they anticipate Indiva Limited (NDVA.V)'s stock price to reach C$0.55 in the next year. This suggests a possible upside of 115.7% from the stock's current price.
View analysts' price targets for Indiva Limited (NDVA.V)
.

Who are some of Indiva Limited (NDVA.V)'s key competitors?

What other stocks do shareholders of Indiva Limited (NDVA.V) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Indiva Limited (NDVA.V) investors own include Canopy Growth (CGC), Curaleaf (CURLF), Dynavax Technologies (DVAX), Heat Biologics (HTBX), OrganiGram (OGI), Vaxart (VXRT), Aurora Cannabis (ACB), Acasti Pharma (ACST), Allena Pharmaceuticals (ALNA) and Energy Transfer (ET).

Who are Indiva Limited (NDVA.V)'s key executives?

Indiva Limited (NDVA.V)'s management team includes the following people:
  • Mr. Carmine Marotta, Co-Founder, Pres, CEO & Director
  • Ms. Jennifer Welsh, Chief Financial Officer
  • Mr. Dave Paterson, Chief Commercial Officer
  • Mr. Robert William Carse, VP of Operations
  • Ms. Kate Abernathy, VP of Marketing & Communications

What is Indiva Limited (NDVA.V)'s stock symbol?

Indiva Limited (NDVA.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "NDVA."

How do I buy shares of Indiva Limited (NDVA.V)?

Shares of NDVA and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Indiva Limited (NDVA.V)'s stock price today?

One share of NDVA stock can currently be purchased for approximately C$0.26.

How big of a company is Indiva Limited (NDVA.V)?

Indiva Limited (NDVA.V) has a market capitalization of C$27.62 million and generates C$5.08 million in revenue each year. Indiva Limited (NDVA.V) employs 95 workers across the globe.

What is Indiva Limited (NDVA.V)'s official website?

The official website for Indiva Limited (NDVA.V) is indiva.ca.

How can I contact Indiva Limited (NDVA.V)?

The company can be reached via phone at 888-649-6686.

This page was last updated on 10/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.